drugset / Trial / NCT04131829

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

NCT04131829

RandomizedParallel-groupDouble-blindBasic science

Summary

The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.

Timeline

Start
2019-10-14
Primary completion
2026-06-30
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule